8-K - Health Catalyst, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Health Catalyst, Inc. entered into a transition agreement with former CEO Daniel Burton, appointing him as Strategic Advisor until December 31, 2026, following his retirement effective February 12, 2026.

Key Takeaways

1Daniel Burton retired as CEO effective February 12, 2026, and from the Board effective February 17, 2026.

2Burton to serve as Strategic Advisor from March 1, 2026, through December 31, 2026, with $10,000 monthly salary.

3All unvested equity awards forfeited as of March 3, 2026.

4Transition supports orderly handover of CEO responsibilities.

5Agreement includes general release of claims and non-disparagement.

6Burton subject to ongoing confidentiality and non-compete during transition.

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previous

Management Change

$10000.00B

9.01

. Financial Statements and Exhibits (d) Exhibits. Exhibit No.: 10.1 | Description: Transition Agreement, dated March 31, 2026, between the Company and Daniel Bu

Exhibits Only

Executive & Director Changes

Daniel Burton

Chief Executive Officer and principal executive officer

Retirement and transition to Strategic Advisor

Effective: 2026-02-12 (retirement); 2026-03-01 (transition)

Acceleration of retirement for smooth transition

Exhibits (2)

10.1

EX-10.1

8-K